Psychedelic research trials in Israel
27registered studies counted
8recruiting, as reported
Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events
NCT07469098Phase 2 · Pardesiyya; Beersheba, IsraelPsilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
NCT07183748Phase 2 · Beersheba, IsraelSafety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
NCT07079930Phase 1 · Jerusalem, IsraelTrauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD
NCT07737054Early Phase 1 · Tel Aviv, IsraelIntensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104Phase 3 · Ramat Gan, IsraelEvaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
NCT04882839Phase 2 · Beersheba, IsraelExamining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury
NCT06394284Phase 3 · Jerusalem, IsraelPreliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.
NCT05732155Phase 2 · Afula, Israel
Country is taken from the study's linked research site. Ketamine counts only when classified as psychiatric research.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and PsychoactiveMap does not recruit, screen or refer participants. Status is copied from the registry and can be out of date, so check the registry record. Disclaimer
Data: PsychoactiveMap as of 31 October 2026